Aveo Pharmaceuticals Files To Sell Up To $86.3M In IPO - Wall Street Journal PDF Print
Wall Street JournalAveo launched a Phase III trial this month of tivozanib in patients with advanced renal cell cancer. Proceeds also will go to support research and

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.